Korea Investment CORP Invests $34.58 Million in Humana Inc. $HUM

Korea Investment CORP acquired a new position in Humana Inc. (NYSE:HUM) during the 2nd quarter, according to its most recent filing with the SEC. The fund acquired 87,053 shares of the insurance provider’s stock, valued at approximately $34,579,000.

Other large investors have also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new position in Humana during the 2nd quarter valued at about $4,138,160,000. Pzena Investment Management LLC acquired a new position in Humana during the second quarter worth about $1,749,014,000. Capital International Investors lifted its holdings in shares of Humana by 113.9% in the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after purchasing an additional 3,097,571 shares in the last quarter. Norges Bank purchased a new stake in shares of Humana in the fourth quarter valued at about $456,632,000. Finally, Wellington Management Group LLP lifted its holdings in shares of Humana by 4,481.7% in the fourth quarter. Wellington Management Group LLP now owns 1,196,502 shares of the insurance provider’s stock valued at $306,460,000 after purchasing an additional 1,170,387 shares in the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the stock. Bank of America raised shares of Humana from a “neutral” rating to a “buy” rating and set a $500.00 price objective for the company in a research note on Wednesday, July 29th. Needham & Company LLC began coverage on Humana in a research note on Wednesday, May 20th. They issued a “buy” rating on the stock. Wolfe Research upgraded Humana from a “peer perform” rating to an “outperform” rating in a report on Thursday, July 30th. Wells Fargo & Company raised Humana from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $227.00 to $502.00 in a research report on Monday, July 13th. Finally, Weiss Ratings raised Humana from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, August 14th. Fourteen research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $395.22.

Humana Price Performance

Humana stock opened at $379.22 on Friday. The stock has a market capitalization of $45.54 billion, a P/E ratio of 35.88, a P/E/G ratio of 2.17 and a beta of 0.72. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $428.88. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. The firm’s 50-day moving average is $383.38 and its two-hundred day moving average is $281.59.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. The business had revenue of $40.89 billion during the quarter, compared to analyst estimates of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company’s revenue was up 26.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $6.27 earnings per share. Equities analysts predict that Humana Inc. will post 9.08 earnings per share for the current year.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.